MELISSA GILBERT: Open Payments
NPI 1760631170 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 45 payments from 12 companies in 2025. Trend: 2023 $456 · 2024 $906 · 2025 $1,274
Food & beverage: $1,179Education: $96
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $343 |
| Amgen Inc. | 8 | $226 |
| GENZYME CORPORATION | 4 | $176 |
| ABBVIE INC. | 10 | $167 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $122 |
| LEO Pharma Inc. | 2 | $49 |
| Janssen Biotech, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| PFIZER INC. | 1 | $29 |
Products named: DUPIXENT, Winlevi, SKYRIZI, Otezla, ADBRY, RINVOQ, TREMFYA, OPZELURA.
Industry payments across CA — which companies pay providers there.
